44.16 USD
-1.97 (-4.27%)
CTRN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 122 industry peers in the Specialty Retail industry. While CTRN seems to be doing ok healthwise, there are quite some concerns on its profitability. CTRN has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year CTRN has reported negative net income.
CTRN had a positive operating cash flow in the past year.
In multiple years CTRN reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: CTRN reported negative operating cash flow in multiple years.
1.2 Ratios
With a Return On Assets value of -3.53%, CTRN is not doing good in the industry: 64.75% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -15.19%, CTRN is in line with its industry, outperforming 42.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.53% | ||
| ROE | -15.19% | ||
| ROIC | N/A |
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-3.45%
ROE(5y)11.58%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CTRN has a Gross Margin of 39.53%. This is comparable to the rest of the industry: CTRN outperforms 59.84% of its industry peers.
CTRN's Gross Margin has been stable in the last couple of years.
CTRN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.53% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.05%
GM growth 5Y-0.3%
2. Health
2.1 Basic Checks
CTRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CTRN remains at a similar level compared to 1 year ago.
CTRN has less shares outstanding than it did 5 years ago.
There is no outstanding debt for CTRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
CTRN has an Altman-Z score of 3.11. This indicates that CTRN is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.11, CTRN is doing good in the industry, outperforming 73.77% of the companies in the same industry.
CTRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 3.11 |
ROIC/WACCN/A
WACC9.72%
2.3 Liquidity
CTRN has a Current Ratio of 1.07. This is a normal value and indicates that CTRN is financially healthy and should not expect problems in meeting its short term obligations.
CTRN has a Current ratio of 1.07. This is in the lower half of the industry: CTRN underperforms 68.85% of its industry peers.
CTRN has a Quick Ratio of 1.07. This is a bad value and indicates that CTRN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CTRN (0.38) is worse than 60.66% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.07 | ||
| Quick Ratio | 0.38 |
3. Growth
3.1 Past
CTRN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.31%.
CTRN shows a small growth in Revenue. In the last year, the Revenue has grown by 5.77%.
Measured over the past years, CTRN shows a decrease in Revenue. The Revenue has been decreasing by -0.75% on average per year.
EPS 1Y (TTM)-22.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.82%
Revenue 1Y (TTM)5.77%
Revenue growth 3Y-8.76%
Revenue growth 5Y-0.75%
Sales Q2Q%10.07%
3.2 Future
CTRN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.07% yearly.
Based on estimates for the next years, CTRN will show a small growth in Revenue. The Revenue will grow by 5.80% on average per year.
EPS Next Y80.51%
EPS Next 2Y46.83%
EPS Next 3Y34.3%
EPS Next 5Y24.07%
Revenue Next Year8.45%
Revenue Next 2Y6.28%
Revenue Next 3Y6.43%
Revenue Next 5Y5.8%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CTRN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
CTRN is valuated quite expensively with a Price/Forward Earnings ratio of 61.85.
CTRN's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 23.57. CTRN is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 61.85 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CTRN is valued a bit more expensive than the industry average as 68.03% of the companies are valued more cheaply.
63.11% of the companies in the same industry are more expensive than CTRN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.72 | ||
| EV/EBITDA | 52.93 |
4.3 Compensation for Growth
CTRN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CTRN's earnings are expected to grow with 34.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.83%
EPS Next 3Y34.3%
5. Dividend
5.1 Amount
CTRN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:CTRN (1/7/2026, 8:00:01 PM)
44.16
-1.97 (-4.27%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners91.73%
Inst Owner Change0%
Ins Owners10.77%
Ins Owner Change-0.02%
Market Cap366.97M
Revenue(TTM)800.74M
Net Income(TTM)-16.38M
Analysts82.5
Price Target56.61 (28.19%)
Short Float %6.41%
Short Ratio4.62
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.79%
Min EPS beat(2)-9.21%
Max EPS beat(2)20.8%
EPS beat(4)2
Avg EPS beat(4)-185.43%
Min EPS beat(4)-938.78%
Max EPS beat(4)185.47%
EPS beat(8)2
Avg EPS beat(8)-131.97%
EPS beat(12)4
Avg EPS beat(12)-112.68%
EPS beat(16)7
Avg EPS beat(16)-76.95%
Revenue beat(2)1
Avg Revenue beat(2)1.21%
Min Revenue beat(2)-0.73%
Max Revenue beat(2)3.15%
Revenue beat(4)2
Avg Revenue beat(4)0.31%
Min Revenue beat(4)-2.13%
Max Revenue beat(4)3.15%
Revenue beat(8)2
Avg Revenue beat(8)-1.2%
Revenue beat(12)3
Avg Revenue beat(12)-1.37%
Revenue beat(16)5
Avg Revenue beat(16)-1.74%
PT rev (1m)15.63%
PT rev (3m)15.63%
EPS NQ rev (1m)0%
EPS NQ rev (3m)37.23%
EPS NY rev (1m)10.71%
EPS NY rev (3m)10.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)7%
Revenue NY rev (1m)2.33%
Revenue NY rev (3m)2.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 61.85 | ||
| P/S | 0.46 | ||
| P/FCF | 30.72 | ||
| P/OCF | 12.25 | ||
| P/B | 3.4 | ||
| P/tB | 3.4 | ||
| EV/EBITDA | 52.93 |
EPS(TTM)-3.07
EYN/A
EPS(NY)0.71
Fwd EY1.62%
FCF(TTM)1.44
FCFY3.26%
OCF(TTM)3.61
OCFY8.17%
SpS96.36
BVpS12.98
TBVpS12.98
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.53% | ||
| ROE | -15.19% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.53% | ||
| FCFM | 1.49% |
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-3.45%
ROE(5y)11.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.05%
GM growth 5Y-0.3%
F-Score6
Asset Turnover1.72
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 99.92% | ||
| Cap/Sales | 2.25% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 502.11% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.07 | ||
| Quick Ratio | 0.38 | ||
| Altman-Z | 3.11 |
F-Score6
WACC9.72%
ROIC/WACCN/A
Cap/Depr(3y)80.1%
Cap/Depr(5y)94.79%
Cap/Sales(3y)2.05%
Cap/Sales(5y)2.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.82%
EPS Next Y80.51%
EPS Next 2Y46.83%
EPS Next 3Y34.3%
EPS Next 5Y24.07%
Revenue 1Y (TTM)5.77%
Revenue growth 3Y-8.76%
Revenue growth 5Y-0.75%
Sales Q2Q%10.07%
Revenue Next Year8.45%
Revenue Next 2Y6.28%
Revenue Next 3Y6.43%
Revenue Next 5Y5.8%
EBIT growth 1Y64.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year128.1%
EBIT Next 3Y46.12%
EBIT Next 5Y30.92%
FCF growth 1Y164.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y855.19%
OCF growth 3YN/A
OCF growth 5YN/A
CITI TRENDS INC / CTRN FAQ
What is the fundamental rating for CTRN stock?
ChartMill assigns a fundamental rating of 3 / 10 to CTRN.
What is the valuation status for CTRN stock?
ChartMill assigns a valuation rating of 3 / 10 to CITI TRENDS INC (CTRN). This can be considered as Overvalued.
How profitable is CITI TRENDS INC (CTRN) stock?
CITI TRENDS INC (CTRN) has a profitability rating of 2 / 10.
What is the financial health of CITI TRENDS INC (CTRN) stock?
The financial health rating of CITI TRENDS INC (CTRN) is 6 / 10.
Can you provide the dividend sustainability for CTRN stock?
The dividend rating of CITI TRENDS INC (CTRN) is 0 / 10 and the dividend payout ratio is 0%.